Bicara Therapeutics (BCAX) News Today $11.91 -0.11 (-0.92%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$11.91 0.00 (0.00%) As of 08/28/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BCAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Wellington Management Group LLP Has $18.17 Million Holdings in Bicara Therapeutics Inc. $BCAXAugust 28 at 4:41 AM | marketbeat.comBicara Therapeutics to Participate in Upcoming Investor ConferencesAugust 27 at 4:01 PM | globenewswire.comHC Wainwright Cuts Bicara Therapeutics (NASDAQ:BCAX) Price Target to $40.00August 25, 2025 | americanbankingnews.comHC Wainwright Lowers Bicara Therapeutics (NASDAQ:BCAX) Price Target to $40.00August 24, 2025 | marketbeat.comBicara Therapeutics price target lowered to $40 from $41 at H.C. WainwrightAugust 22, 2025 | msn.comPiper Sandler Initiates Coverage of Bicara Therapeutics (BCAX) with Overweight RecommendationAugust 19, 2025 | msn.comBicara Therapeutics initiated with an Overweight at Piper SandlerAugust 18, 2025 | msn.comCantor Fitzgerald Has Weak Estimate for BCAX FY2025 EarningsAugust 17, 2025 | marketbeat.comQ3 EPS Estimate for Bicara Therapeutics Reduced by AnalystAugust 17, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPSAugust 13, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Earns Outperform Rating from WedbushAugust 13, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Trading 8.1% Higher - What's Next?August 13, 2025 | marketbeat.comBicara Therapeutics Inc.: Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 13, 2025 | finanznachrichten.deBicara Therapeutics reports Q2 EPS (50c), consensus (54c)August 13, 2025 | msn.comBicara Therapeutics expects cash to fund operations into 1H of 2029August 13, 2025 | msn.comBicara Therapeutics Reports Q2 2025 Results and ProgressAugust 13, 2025 | tipranks.comBicara Therapeutics (NASDAQ:BCAX) Shares Down 4.2% - Here's What HappenedAugust 12, 2025 | marketbeat.comBicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 12, 2025 | globenewswire.comBicara Therapeutics Inc. (NASDAQ:BCAX) Given Consensus Rating of "Buy" by AnalystsAugust 8, 2025 | marketbeat.comJefferies Financial Group Inc. Invests $399,000 in Bicara Therapeutics Inc. (NASDAQ:BCAX)August 7, 2025 | marketbeat.comBicara Therapeutics (BCAX) Expected to Announce Earnings on TuesdayAugust 6, 2025 | marketbeat.comTD Asset Management Inc Purchases 28,518 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX)August 5, 2025 | marketbeat.comVictory Capital Management Inc. Purchases Shares of 34,430 Bicara Therapeutics Inc. (NASDAQ:BCAX)August 3, 2025 | marketbeat.com119,833 Shares in Bicara Therapeutics Inc. (NASDAQ:BCAX) Bought by Atle Fund Management ABJuly 19, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Trading 8% Higher - Here's WhyJuly 14, 2025 | marketbeat.comBicara Therapeutics Inc. (NASDAQ:BCAX) Receives Average Rating of "Buy" from BrokeragesJuly 14, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Stock Price Up 7.3% - Here's WhyJune 30, 2025 | marketbeat.comBicara Therapeutics Inc News (BCAX) - Investing.comJune 27, 2025 | investing.comBicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Rating of "Buy" from AnalystsJune 19, 2025 | marketbeat.com# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trialJune 13, 2025 | investing.comBicara Therapeutics (NASDAQ:BCAX) Stock Price Down 4.6% - What's Next?June 11, 2025 | marketbeat.comBicara Therapeutics Inc. (NASDAQ:BCAX) Holdings Raised by Bank of America Corp DEJune 11, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Stock Price Up 6.7% - Here's WhyJune 10, 2025 | marketbeat.comEquities Analysts Offer Predictions for BCAX FY2026 EarningsJune 10, 2025 | marketbeat.comBCAX Bicara Therapeutics Inc.June 8, 2025 | seekingalpha.comBicara Therapeutics Expands Boston Headquarters with New LeaseJune 6, 2025 | tipranks.com25,028 Shares in Bicara Therapeutics Inc. (NASDAQ:BCAX) Purchased by Nuveen Asset Management LLCJune 6, 2025 | marketbeat.comBicara Therapeutics (NASDAQ:BCAX) Sees Large Volume Increase - Still a Buy?June 4, 2025 | marketbeat.comBicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceJune 3, 2025 | globenewswire.comBicara Therapeutics (NASDAQ:BCAX) Trading 7.5% Higher - Time to Buy?June 3, 2025 | marketbeat.comBicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025June 1, 2025 | globenewswire.comBicara Therapeutics Inc. (NASDAQ:BCAX) Shares Bought by Millennium Management LLCMay 28, 2025 | marketbeat.comStifel Reaffirms Buy Rating on BCAX After Promising ASCO Data for HPV-Negative PatientsMay 26, 2025 | insidermonkey.com112,476 Shares in Bicara Therapeutics Inc. (NASDAQ:BCAX) Acquired by Deutsche Bank AGMay 26, 2025 | marketbeat.com159,043 Shares in Bicara Therapeutics Inc. (NASDAQ:BCAX) Purchased by Northern Trust CorpMay 26, 2025 | marketbeat.comBicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Recommendation of "Buy" from BrokeragesMay 26, 2025 | marketbeat.comWells Fargo & Company Upgrades Bicara Therapeutics (NASDAQ:BCAX) to Equal WeightMay 25, 2025 | marketbeat.comWedbush Reaffirms "Outperform" Rating for Bicara Therapeutics (NASDAQ:BCAX)May 25, 2025 | marketbeat.comWells Fargo Upgrades Bicara Therapeutics (BCAX)May 24, 2025 | msn.comBicara Therapeutics to present head and neck cancer study dataMay 23, 2025 | investing.com Get Bicara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCAX Media Mentions By Week BCAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCAX News Sentiment▼0.211.03▲Average Medical News Sentiment BCAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCAX Articles This Week▼74▲BCAX Articles Average Week Get the Latest News and Ratings for BCAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CPRX News Today ALVO News Today KNSA News Today OGN News Today TARS News Today CNTA News Today DNLI News Today AGIO News Today IDYA News Today IBRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCAX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access